---
id: ITE-2022-153
type: ITE
year: 2022
number: 153
created: 2025-08-08 07:54:57.706114
tags:
- ITE
- question
- ITE-2022
answer: B
topic: null
related_articles:
- title: Metformin vs. Lifestyle Changes for Prevention of Type 2 Diabetes Mellitus.
  path: 2023/2023-04-metformin-vs-lifestyle-changes-for-prevention-of-type-2-diab.md
  similarity: 1.0
  link: '[[2023/2023-04-metformin-vs-lifestyle-changes-for-prevention-of-type-2-diab|Metformin
    vs. Lifestyle Changes for Prevention of Type 2 Diabetes Mellitus.]]'
- title: 2023-05-index
  path: 2023/2023-05-index.md
  similarity: 1.0
  link: '[[2023/2023-05-index|2023-05-index]]'
- title: 'Should Metformin Continue as First-Line Pharmacotherapy for Patients With
    Type 2 Diabetes? Yes: Metformin Is Still the Best Choice.'
  path: 2024/2024-03-should-metformin-continue-as-first-line-pharmacotherapy-for.md
  similarity: 1.0
  link: '[[2024/2024-03-should-metformin-continue-as-first-line-pharmacotherapy-for|Should
    Metformin Continue as First-Line Pharmacotherapy for Patients With Type 2 Diabetes?
    Yes: Metformin Is Still the Best Choice.]]'
- title: Older Treatments for Type 2 Diabetes Mellitus Do Not Affect Patient-Oriented
    Outcomes.
  path: 2023/2023-11-older-treatments-for-type-2-diabetes-mellitus-do-not-affect.md
  similarity: 0.8
  link: '[[2023/2023-11-older-treatments-for-type-2-diabetes-mellitus-do-not-affect|Older
    Treatments for Type 2 Diabetes Mellitus Do Not Affect Patient-Oriented Outcomes.]]'
- title: Tirzepatide (Mounjaro) for the Treatment of Type 2 Diabetes Mellitus.
  path: 2023/2023-07-tirzepatide-mounjaro-for-the-treatment-of-type-2-diabetes-me.md
  similarity: 0.8
  link: '[[2023/2023-07-tirzepatide-mounjaro-for-the-treatment-of-type-2-diabetes-me|Tirzepatide
    (Mounjaro) for the Treatment of Type 2 Diabetes Mellitus.]]'
topics:
- Critical Care
- Emergency Medicine
related_articles_2023_2025:
- title: afp clinical answers
  path: 2023/12/2023-12-afp-clinical-answers.md
  similarity: 0.305
  link: '[[2023/12/2023-12-afp-clinical-answers|afp clinical answers]]'
last_updated: '2025-08-10T20:25:32.361596'
---

# Question ITE-2022-153

and allocating limited critical care resources when demand is greater than supply. Which one of the following processes is consistent with ethically sound crisis standards of care?

## Options

**A.** Making triage decisions based on social and community value

**B.** Explaining triage decision practices and providing a process for appealing decisions

**C.** Allocating limited resources on a first-come, first-served basis when unable to

**D.** Continuing a patientâ€™s treatment without reassessment once resources have been

## Answer

**B**

## Explanation

The American Medical Association Code of Medical Ethics offers helpful guidance for making difficult
decisions, including triage and reassessment decisions, when health care resources are limited during crisis
situations. Explaining triage decision policies and procedures and providing patients who are denied initial
resources a process for appealing decisions is a recommended process and the most ethically sound option
of those listed. It is also recommended to make triage decisions based (see [[Articles/2023/2023-05-diabetes-management-primary-care.md|Diabetes Management in Primary Care: Evidence-Based Approaches]]) on medical need rather than social
worth, and to allocate limited resources first to prevent premature death and then to those with the greatest
duration of benefit after recovery. When unable to distinguish need based on medical factors, a random
process or lottery is recommended rather than a first-come, first-served process since patients with
obstacles to care who cannot present first would be unfairly disadvantaged. Reassessment of whether
continued treatment is likely to be beneficial should oc...



## Related Articles

- [[Articles/2023/2023-05-diabetes-management-primary-care.md|Diabetes Management in Primary Care: Evidence-Based Approaches]]

## References

*[To be added from answer key]*
